On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2013: Volume 18/ Issue 50 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 18, Issue 50, 12 December 2013
Rapid communications
Cluster of Legionnaires’ disease cases caused by Legionella longbeachae serogroup 1, Scotland, August to September 2013
  1. Health Protection Scotland, Glasgow, Scotland, United Kingdom
  2. Health Protection Team, NHS Lothian, Edinburgh, Scotland, United Kingdom
  3. Health Protection Team, NHS Tayside, Dundee, Scotland, United Kingdom
  4. Scottish Haemophilus Legionella Meningococcus Pneumococcus Reference Laboratory, Glasgow, Scotland, United Kingdom
  5. Microbiology Department, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, Scotland, United Kingdom

Citation style for this article: Potts A, Donaghy M, Marley M, Othieno R, Stevenson J, Hyland J, Pollock KG, Lindsay D, Edwards G, Hanson MF, Helgason KO. Cluster of Legionnaires’ disease cases caused by Legionella longbeachae serogroup 1, Scotland, August to September 2013 . Euro Surveill. 2013;18(50):pii=20656. Article DOI:
Date of submission: 18 November 2013

We report six confirmed cases of Legionnaires’ disease in Scotland caused by Legionella longbeachae serogroup 1, identified over a four-week period in August–September 2013. All cases required admission to hospital intensive care facilities. All cases were amateur gardeners with frequent exposure to horticultural growing media throughout their incubation period. L. longbeachae was identified in five samples of growing media linked to five cases. Product tracing did not identify a common product or manufacturer.

We describe a cluster of Legionnaires’ disease cases caused by Legionella longbeachae identified in Scotland between August and September 2013. This was an unprecedented cluster due to the number of cases identified in such a short time period and the geographical proximity of the cases. A national Incident Management Team (IMT) investigated this cluster, focussing on epidemiological, clinical microbiology and environmental issues.

Scotland, with a population of 5.2 million inhabitants, usually records 20–45 cases of Legionnaires’ disease per year, of which around 60% are travel-related [1]. Since 2008, a small but increasing number of cases of Legionnaires’ disease caused by L. longbeachae have been identified in Scotland. This amounts to 18 cases since 2008, with eight cases in 2013, as of 18 November [2, unpublished data for 2013]. This increase has not been mirrored across the rest of the United Kingdom (UK) and Europe. In 2012, a national IMT investigated the 10 cases detected between 2008 and 2012. The investigation focussed on: case ascertainment; case characteristics; growing media production; and a discussion of whether additional public health action was warranted [2]. It identified that the most likely reason for case ascertainment in Scotland but not the rest of the UK, was the testing protocol in use, driven by an active Scottish Legionella Reference Laboratory (SHLMPRL) that routinely used a Legionella species PCR test and L. longbeachae specific serology tests. These tests were not routinely used in the rest of the UK. No differences in production of horticultural growing media in Scotland and the rest of the UK were identified [2].

Investigation of the cluster

Incident management
Following identification of two confirmed (culture positive) cases of L. longbeachae and an additional suspected third case (Legionella species PCR positive), NHS Lothian (one of the health boards in Scotland) called a Problem Assessment Group on 6 September 2013. Upon confirmation of the third case (by culture), identification of a fourth suspected case and another confirmed case in neighbouring NHS Tayside, a national IMT meeting was held on 12 September 2013. Leadership of the investigation was passed to Health Protection Scotland (HPS), the national organisation for health protection in Scotland.

Information about presentation of illness, details of testing and background information on L. longbeachae was provided to local medical services in NHS Lothian and Tayside, including general practice, emergency care, respiratory wards and to the national health helpline (NHS24), following the first IMT meeting. All health boards in Scotland received public health alerts highlighting the situation. Other UK countries also received these alerts and the European Centre for Disease Prevention and Control (ECDC) was informed.

There was significant press interest in this cluster of cases. Reactive media statements were prepared after every IMT meeting. Following press reporting of this cluster, representatives from growing media retailers approached HPS for advice they could provide to customers to reduce risk of illness. Growing media retailers have had increased awareness of Legionnaires’ disease from press reporting of cases in Scotland since 2008. A statement was developed for the retail industry describing the low risk of infection and highlighting general gardening hygiene. 

Epidemiological investigation
Case definitions are detailed in Table 1. These were adapted from the ECDC case definitions [3] with additional details of time, place and exposure. A ‘possible’ category was introduced to include those who met clinical and epidemiological criteria whilst test results were awaited. In reality, this ‘possible’ category was not used as cases were only notified to public health teams following microbiological analysis establishing them as ‘confirmed’ or ‘probable’ cases. Cases had a date of onset between 11 August and 10 September (Table 2). Cases were confirmed as L. longbeachae infections on average 12 days (range 7–16 days) after the initial diagnosis of community-acquired pneumonia. Due to the relative rarity of this infection, clinicians may not consider Legionnaires’ disease until some time into the diagnostic process. This is particularly likely where there is a negative Legionella urinary antigen test result, which is often used by clinicians to exclude Legionnaires’ disease. Cases were within 130 km of each other, in two neighbouring health board regions.

Table 1. Case definitions for Legionnaires’ disease cases caused by Legionella longbeachae serogroup 1, Scotland, August–September 2013

All confirmed cases were interviewed by nurses in the health board’s health protection team, using a standard questionnaire. This sought details on clinical presentation and testing, travel history, recent hospitalisation, possible water aerosol exposures, possible horticultural growing media exposure, gardening activities. In the first instance, partners and relatives were interviewed, as the cases themselves were too unwell to be interviewed.

All cases had severe community-acquired pneumonia and were all admitted to intensive care facilities. They remained in hospital for an average of 22 days (variation 11–43 days). The cases comprised of three females and three males with a mean age of 70 years (range 55–84 years). Five out of six cases had health problems contributing to underlying immunosuppression. Five out of six cases were active or ex-tobacco smokers. All cases had lived at home throughout their exposure period of 14 days and had not undertaken any activities outside their usual activity pattern. Five out of six cases were keen amateur gardeners who had regular exposure to horticultural growing media during the incubation period of their illness. One case did not describe any clear exposure to growing media. No other relevant exposures were identified for these cases.

In addition to the six confirmed cases of Legionnaires’ disease there was one case of probable Legionnaires’ disease in a keen gardener with frequent exposure to growing media during the incubation period of their illness. This patient had a moderately high titre of 1:128 to L. longbeachae which reverted to negative on follow up testing; no acute serum sample or sputum was available for testing. This case was clinically less severe than the other cases and was managed in the community. The patient was younger than the other cases and did not have any underlying morbidity. This case was detected some time after the six confirmed cases, but had an estimated date of onset within the four-week period between August and September. This case was diagnosed retrospectively, following treatment for pneumonia and it is likely that detection was due to information about this cluster being circulated to general practice physicians.

Clinical microbiological findings
Cases 1–4 were identified by the local clinical diagnostic laboratory in NHS Lothian, which had implemented testing of severe community-acquired pneumonia lower respiratory tract samples by both L. pneumophila and Legionella species PCR in 2010. Legionella species PCR positive samples were referred to SHLMPRL for confirmation and culture. All isolates were L. longbeachae serogroup 1. Cases 5 and 6 were identified in NHS Tayside shortly after the first Lothian cases. Sputum/bronchial alveolar lavage samples were cultured in the local diagnostic laboratory and Legionella colonies were isolated. These isolates were identified as L. longbeachae serogroup 1. This local diagnostic laboratory did not routinely use a Legionella species PCR test. All patient isolates were genotyped by amplified fragment length polymorphism (AFLP) at SHLMPRL. Testing results are summarised in Table 2.

Table 2. Summary of clinical microbiological testing for the six cases of Legionnaires’ disease caused by Legionella longbeachae serogroup 1, Scotland, August–September 2013

Environmental investigation

The environmental investigation focussed on three main areas:

  1. identifying specific gardening activities and exposures which may be considered as a high risk;
  2. establishing sources through microbiological testing;
  3. tracing supply chain and manufacture of potential sources.

There was no common theme in gardening activities and no particular single gardening activity or garden exposure was common amongst the cases, other than use of recently purchased shop-bought growing media. Samples of any remaining growing media were taken for microbiological testing.

In five out of six cases, the use of growing media was investigated. Shop-bought growing media was of a range of brands bought in different premises. All had been stored at home inside, either in the cases’ house or greenhouse/polytunnel/garden shed/garage. Using the barcodes on the bags of growing media, batch number and manufacturer details were obtained. There was no common manufacturing site; manufacturing sites were located in England, Scotland and Northern Ireland. Of those growing media produced at the same manufacturing site, there was no common batch number. In addition, there was no common supplier of composted material to these manufacturing sites. All of these growing media contained composted green material and four out of five contained peat.

Microbiological testing of bagged growing media and other garden samples obtained from the cases’ homes, detected L. longbeachae serogroup 1 in five out of 11 samples tested, resulting in positive growing media samples linked to five cases. In all cases, the same AFLP DNA profile was found in the patient isolate and the implicated growing media isolate. Each patient and growing media isolate was identified as one of three circulating AFLP types regularly identified in Scotland. The genetic similarity or diversity of all the strains is currently being analysed by whole genome sequencing. Given the match in organism and exposure during the incubation period, it is highly likely that these growing media were the source of infection for these cases. Further work is ongoing looking at further genetic analysis and comparison of the L. longbeachae clinical and environmental isolates, using whole genome sequencing.


Detection of L. longbeachae infection is unusual in Europe with 43 cases reported to the European Surveillance System (Tessy) between 2005 and 2012 (personal communication, Encarna Gimenez, September 2013). Diagnosis of Legionnaires’ disease in the European Union relies heavily on urinary antigen testing that does not detect L. longbeachae. Culture has always been the gold standard for the definitive diagnosis of Legionnaires’ disease [3]. However, Legionella culture requires specific laboratory media and expertise; it may miss cases that would be detected by PCR [4] and results may not be available in a timely manner to allow effective clinical and public health action. Detection of the four Lothian cases relied on the local diagnostic service using a Legionella species PCR test, a test which, to our knowledge, no other diagnostic laboratory in the UK uses. In addition to culture and PCR, a four-fold change in titre to a L. longbeachae specific antibody was seen in the three cases from whom sufficient samples were taken. Serological diagnosis of Legionnaires’ disease for serogroups and species other than L. pneumophila serogroup 1 has never been fully validated because of the rarity of these infections. However, in cases of severe Legionnaires’ disease, a Legionella species-specific positive PCR and a greater than four-fold rise in titre to a particular Legionella species, have helped to verify the causative organism. These data support the growing suspicion that L. longbeachae infection is under-ascertained in Scotland and probably across Europe. Following detection of this cluster, Public Health England has implemented a Legionella species PCR test in the National Reference Laboratory for a trial period. Assessment of this should take into account the possible seasonal nature of L. longbeachae infections, coinciding with seasonal use of growing media. It is also recommended that national surveillance units consider ways of raising awareness amongst frontline clinical staff, to consider the diagnosis of Legionnaires’ disease (including non-pneumophila species infections) in those with community-acquired pneumonia.

L. longbeachae infection accounts for approximately half of all cases of Legionnaires’ disease in Australia [5] and New Zealand [6], where growing media is peat-free and a major component is composted green material such as pine woodchip and bark. Predominantly peat-based growing media is used in Europe and this is likely to be a low risk for L. longbeachae contamination. In the UK, there is political pressure and legislation in place to reduce the volume of peat used in growing media to preserve peat stocks [7]. As peat is phased out, the volume of composted green material in growing media will increase. It is therefore likely that we will see increasing numbers of cases of Legionnaires’ disease caused by L. longbeachae infection, providing that we can detect them. 

No single source of contaminated growing media could be identified in this cluster, which supports research findings that L. longbeachae is ubiquitous in soils and growing media [8,9]. Growing media manufactured in the UK for retail is required to meet manufacturing standards (PAS 100 [10]) which includes some microbiological testing, but not testing for Legionella bacteria. As in many other infections, a combination of infectious dose, mode of infection and host susceptibility is likely to influence outcome. It is not clear whether clinical infection follows inhalation of a particular infectious dose of bacteria, or at which stage in the manufacturing and/or retail process a bacterial load might be reached which poses a risk to susceptible individuals. It is possible that higher concentrations of Legionella bacteria develop during storage of growing media prior to use. All of the cases in this cluster with exposure to growing media had stored bags of growing media in their home or in sheds or other enclosed spaces. It is possible that the unusually warm summer in Scotland in 2013 caused a rise in temperature of the growing media during the day whilst being protected from cool nights indoors, providing opportunity for the Legionella to grow and resulting in a higher than usual concentration of these organisms in the product. 

Members of the Incident Management Team (IMT)
Martin Donaghy, Consultant in Public Health Medicine and Strategic Lead for Legionellosis, Health Protection Scotland; Alison Potts, Epidemiologist, Health Protection Scotland; Kevin G Pollock, Epidemiologist, Health Protection, Scotland; Michelle Marley, Environmental Health Advisor, Health Protection Scotland; Richard Othieno, Consultant in Public Health Medicine, NHS Lothian; Janet Stevenson, Consultant in Public Health Medicine, NHS Lothian; Peter Harrison, Health Protection Nurse, NHS Lothian; Jackie Hyland, Consultant in Public Health Medicine, NHS Tayside; Diane Lindsay, Principal Clinical Scientist, Scottish Haemophilus Legionella Meningococcus Pneumococcus Reference Laboratory; Giles Edwards, Consultant Microbiologist, Scottish Haemophilus Legionella Meningococcus Pneumococcus Reference Laboratory; Kristjan Helgason, Consultant Microbiologist, NHS Lothian; Mary Hanson, Consultant Microbiologist, NHS Lothian; Michael Lockhart, Consultant Microbiologist, NHS Tayside; Robbie Beattie, Scientific Officer, Edinburgh Scientific Services; Margaret Gregory, Senior Environmental Health Officer, Angus Council; Iain McCluskey, Environmental Health Officer, West Lothian Council; Malcolm Elliot, Environmental Health Officer, East Lothian Council; Colin Sibbald, Environmental Health Officer, Edinburgh City Council; Joyce Dalgleish, Communications Lead, Health Protection Scotland; David Reid, Communications Officer, NHS Lothian; Simon Cuthbert-Kerr, Public Health team, Scottish Government; Duncan McCormick, Senior Medical officer, Scottish Government; Nick Phin, Head of Legionella and Influenza Preparedness and Response, Public Health England.

Conflict of interest
None declared.

Authors’ contributions
All authors contributed to the writing of this manuscript and approved the final version.


  1. Health Protection Scotland (HPS). Respiratory Infections. Legionella. Glasgow: HPS. [Accessed 18 Nov 2013]. Available from:,97
  2. Health Protection Scotland (HPS). Respiratory Infections. HPS Publications. Increased incidence of Legionnaires' disease caused by Legionella longbeachae in Scotland: Report from a National Incident Management Team. 12 Sep 2013. Available from:,97
  3. European Centre for Disease Prevention and Control (ECDC). European Legionnaires' Disease Surveillance Network (ELDSNet). EU case definition. Stockholm: ECDC. [Accessed 18 Nov 2013]. Available from:
  4. Murdoch DR, Podmore RG, Anderson TP, Barratt K, Maze MJ, et al. Impact of Routine Systematic Polymerase Chain Reaction Testing on Case Finding for Legionnaires' Disease: A Pre-Post Comparison Study. Clin Infect Dis. 2013;57(9):1275-81.
  5. Australian Government. Department of Health. Australia's notifiable diseases status: Annual report of the National Notifiable Diseases Surveillance System. Canberra: Department of Health. [Accessed 18 Nov 2013]. Available from:
  6. Institute of Environmental Science and Research (ESR). Public Health Surveillance. Notifiable and other diseases in NZ: annual report 2012. Wellington: ESR. [Accessed 18 Nov 2013]. Available from:
  7. Department for Environment, Food & Rural Affairs. Peat Task Force. Sustainable Growing Media Task Force. London: Department for Environment, Food & Rural Affairs. [Accessed 18 Nov 2013]. Available from:
  8. Currie SL, Beattie TK, Knapp CW, Lindsay DSJ. Legionella spp in UK composts – a potential public health issue? Clin Microbiol Infect. 2013 Sep 3. [Epub ahead of print].
  9. Casati S, Conza L, Bruin J, Gaia V. Compost facilities as a reservoir of Legionella pneumophila and other Legionella species. Clin Microbiol Infect. 2010;16(7):945-7.
  10. Waste & Resources Action Programme (WRAP). BSI PAS 100 - Compost specification. Banbury: WRAP. [Accessed 18 Nov 2013]. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.